Similar articles

• BCG immunotherapy of rat sarcomata.

  Baldwin RW, Pimm MV. Baldwin RW, et al. Br J Cancer. 1973 Jul;28(1):79. doi: 10.1038/bjc.1973.84. Br J Cancer. 1973. PMID: 4579636 Free PMC article. No abstract available.
• Tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity.

  Salvin SB, Youngner JS, Nishio J, Neta R. Salvin SB, et al. J Natl Cancer Inst. 1975 Nov;55(5):1233-6. doi: 10.1093/jnci/55.5.1233. J Natl Cancer Inst. 1975. PMID: 1206752
• Effect of anti-thymocyte serum, anti-macrophage serum, and latex particles on the therapeutic efficacy of BCG or Corynebacterium liquefaciens (Propionibacterium acnes C7) in syngeneic mice.

  Tanaka T, Nakagawa H, Kato A, Yoshimura M, Fujita H, Kimura K. Tanaka T, et al. Gan. 1977 Feb;68(1):45-52. Gan. 1977. PMID: 324858
• The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.

  Ettinghausen SE, Rosenberg SA. Ettinghausen SE, et al. Springer Semin Immunopathol. 1986;9(1):51-71. Springer Semin Immunopathol. 1986. PMID: 3523804 Review. No abstract available.
• Immunological intervention in neoplasia.

  Weiss DW. Weiss DW. Johns Hopkins Med J Suppl. 1974;3:131-56. Johns Hopkins Med J Suppl. 1974. PMID: 4371312 Review. No abstract available.